87 related articles for article (PubMed ID: 21932190)
21. Effects of genome architecture and epigenetic factors on susceptibility of promoter CpG islands to aberrant DNA methylation induction.
Takeshima H; Yamashita S; Shimazu T; Ushijima T
Genomics; 2011 Sep; 98(3):182-8. PubMed ID: 21683780
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q.
Yamada Y; Watanabe H; Miura F; Soejima H; Uchiyama M; Iwasaka T; Mukai T; Sakaki Y; Ito T
Genome Res; 2004 Feb; 14(2):247-66. PubMed ID: 14762061
[TBL] [Abstract][Full Text] [Related]
23. Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived.
Ueki T; Walter KM; Skinner H; Jaffee E; Hruban RH; Goggins M
Oncogene; 2002 Mar; 21(13):2114-7. PubMed ID: 11960385
[TBL] [Abstract][Full Text] [Related]
24. Identification of silencing of nine genes in human gastric cancers.
Kaneda A; Kaminishi M; Yanagihara K; Sugimura T; Ushijima T
Cancer Res; 2002 Nov; 62(22):6645-50. PubMed ID: 12438262
[TBL] [Abstract][Full Text] [Related]
25. Epigenomic and enhancer dysregulation in uterine leiomyomas.
Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
[TBL] [Abstract][Full Text] [Related]
26. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.
Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R
Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis.
Hoffman PJ; Milliken DB; Gregg LC; Davis RR; Gregg JP
Fertil Steril; 2004 Sep; 82(3):639-49. PubMed ID: 15374708
[TBL] [Abstract][Full Text] [Related]
28. [Screening the differentially methylated DNA sequences of colorectal cancer by methylated CpG islands amplification coupled with representational difference analysis].
Zhu YM; Lin J; Huang Q; Lai MD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):425-9. PubMed ID: 14556198
[TBL] [Abstract][Full Text] [Related]
29. Genic expression of the uterine leiomyoma in reproductive-aged women after treatment with goserelin.
Borsari R; Bozzini N; Junqueira CR; Soares JM; Hilário SG; Baracat EC
Fertil Steril; 2010 Aug; 94(3):1072-7. PubMed ID: 19481745
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation differences associated with tumor tissues identified by genome scanning analysis.
Liang G; Salem CE; Yu MC; Nguyen HD; Gonzales FA; Nguyen TT; Nichols PW; Jones PA
Genomics; 1998 Nov; 53(3):260-8. PubMed ID: 9799591
[TBL] [Abstract][Full Text] [Related]
31. Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.
Furuta J; Nobeyama Y; Umebayashi Y; Otsuka F; Kikuchi K; Ushijima T
Cancer Res; 2006 Jun; 66(12):6080-6. PubMed ID: 16778180
[TBL] [Abstract][Full Text] [Related]
32. Characterization of uterine leiomyomas by whole-genome sequencing.
Mehine M; Kaasinen E; Mäkinen N; Katainen R; Kämpjärvi K; Pitkänen E; Heinonen HR; Bützow R; Kilpivaara O; Kuosmanen A; Ristolainen H; Gentile M; Sjöberg J; Vahteristo P; Aaltonen LA
N Engl J Med; 2013 Jul; 369(1):43-53. PubMed ID: 23738515
[TBL] [Abstract][Full Text] [Related]
33. Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines.
Imura M; Yamashita S; Cai LY; Furuta J; Wakabayashi M; Yasugi T; Ushijima T
Cancer Lett; 2006 Sep; 241(2):213-20. PubMed ID: 16303245
[TBL] [Abstract][Full Text] [Related]
34. Identification of uterine leiomyoma-specific marker genes based on DNA methylation and their clinical application.
Sato S; Maekawa R; Yamagata Y; Tamura I; Lee L; Okada M; Jozaki K; Asada H; Tamura H; Sugino N
Sci Rep; 2016 Aug; 6():30652. PubMed ID: 27498619
[TBL] [Abstract][Full Text] [Related]
35. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers.
Miyamoto K; Asada K; Fukutomi T; Okochi E; Yagi Y; Hasegawa T; Asahara T; Sugimura T; Ushijima T
Oncogene; 2003 Jan; 22(2):274-80. PubMed ID: 12527896
[TBL] [Abstract][Full Text] [Related]
36. Potential mechanisms of aberrant DNA hypomethylation on the x chromosome in uterine leiomyomas.
Sato S; Maekawa R; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Sugino N
J Reprod Dev; 2014 Mar; 60(1):47-54. PubMed ID: 24291816
[TBL] [Abstract][Full Text] [Related]
37. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
38. Decreased expression of early growth response-1 and its role in uterine leiomyoma growth.
Shozu M; Murakami K; Segawa T; Kasai T; Ishikawa H; Shinohara K; Okada M; Inoue M
Cancer Res; 2004 Jul; 64(13):4677-84. PubMed ID: 15231681
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide profiling of promoter methylation in human.
Hatada I; Fukasawa M; Kimura M; Morita S; Yamada K; Yoshikawa T; Yamanaka S; Endo C; Sakurada A; Sato M; Kondo T; Horii A; Ushijima T; Sasaki H
Oncogene; 2006 May; 25(21):3059-64. PubMed ID: 16407832
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide identification of OTP gene as a novel methylation marker of breast cancer.
Kim MS; Lee J; Oh T; Moon Y; Chang E; Seo KS; Hoehn BD; An S; Lee JH
Oncol Rep; 2012 May; 27(5):1681-8. PubMed ID: 22366991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
